. Author manuscript; available in PMC: 2009 Jun 1.

Published in final edited form as: Clin Infect Dis. 2008 Dec 1;47(11):1479–1485. doi: 10.1086/593104

Table 1.

Baseline characteristics of the study population.

		HBsAg-positive patients
Characteristic	HBsAg-negative patients (n = 431)	HBV DNA level ≤1 × 10⁴ copies/mL (n = 60)	HBV DNA level >1 × 10⁴ copies/mL (n = 46)	P
Sex, proportion (%) of patients
Men	393/417 (94)	57/59 (97)	40/42 (95)	.60
Women	24/417 (6)	2/59 (3)	2/42 (5)
Age, years	41 (36–46)	42 (36–47)	40 (36–46)	.51
Weight, kg	65 (58–70)	64 (58–73)	62 (60–67)	.56
CD4 cell count, cells/mm³	146 (79–224)	174 (114–246)	148 (85–232)	.23
HIV RNA level, log₁₀copies/mL	4.9 (4.5–5.3)	4.8 (4.5–5.2)	5.0 (4.6–5.3)	.45
Maximum ALT or AST level, IU/L	38 (31–58)	40 (31–56)	56 (36–89)	.004
ALT or AST level >ULN^a %	45	46	70	.006
Hemoglobin level, g/dL	12.4 (11–14)	12.6 (11–13)	12.5 (11–14)	.92

NOTE. Data are median value (interquartile range [IQR]), unless otherwise indicated. ALT, alanine aminotransaminase; AST, aspartate aminotransaminase; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; ULN, upper limit of normal.

The ULN for ALT and AST was 40 IU/L.